Work

Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.4540

Authors: G. Philips, S. Halabi, B. Sanford, D. Bajorin, E. Small

Institutions: University of Vermont, Memorial Sloan Kettering Cancer Center, University of California, San Francisco

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604350448

Cites:

Cited by: 14

Related to: 10